News | June 03, 2022
CMP Pharma announces calcium channel blocker ‘Norliqva’ availability
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
This agreement is in addition to the $92 million filling line expansion announced in November 2021
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
